Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on June 2, 2026

Jun. 2, 2026

AdPlus Claims adplus.com and adplus.ai as Platform Nears 400 Users and Surpasses 750 Campaigns

Indeterminate EIN Presswire

Jun. 2, 2026

Sokolove Law Managing Attorney Ricky LeBlanc Recognized for 35 Years of 'Proudly Serving the Community'

Indeterminate EIN Presswire

Jun. 2, 2026

Boston Gynecomastia Specialists Report Sheds Light on the Link Between Bigorexia / Muscle Dysmorphia and Gynecomastia

Indeterminate EIN Presswire

Jun. 2, 2026

WATERSTONE PROPERTIES GROUP & DRA Advisors ACQUIRE HAMMOCK LANDING IN FLORIDA

Indeterminate EIN Presswire

Jun. 2, 2026

Data Plus Unveils GEN 9: DP Finance AI Cloud — Next Generation of AI-First Hospitality Financial Management

Indeterminate EIN Presswire

Jun. 2, 2026

Uplizd Offers Custom Agentic AI Infrastructure to Revolutionize Biologic Formulation Development in Pharmaceutical R&D

Indeterminate EIN Presswire

Jun. 2, 2026

'Negotiating with Trump,' Peter D. Johnston’s Analysis of Trump’s Negotiation Style, Released

Indeterminate EIN Presswire

Jun. 2, 2026

Nonprofit Finance Fund Presents its 'Full Cost Framework' at GEO Conference for Philanthropy Leaders

Indeterminate EIN Presswire

Jun. 2, 2026

TheAnswerPage.com Launches 6-hour CME/CE Program to Support Clinicians, Health Systems & State Medical Cannabis Programs

Indeterminate EIN Presswire

Jun. 2, 2026

Retail & Logistics Security and Technology Pioneer Tom Meehan Joins EAIGLE’s Board of Advisors

Indeterminate EIN Presswire

Jun. 2, 2026

AI Workforce Question Heads to Boston as 400+ Natural Gas Decision-Makers Convene for LDC Gas Forums Northeast

Indeterminate EIN Presswire

Jun. 2, 2026

Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine

Indeterminate GlobeNewswire

Jun. 2, 2026

New Amplif.AI Professional Chart Review Helps Providers Close AI-Generated Notes Faster, Accurately, & More Defensibly

Indeterminate EIN Presswire

Jun. 2, 2026

ATN International, Inc. Completes Initial Closing on the Sale of its Towers and Updates 2026 Outlook

Indeterminate GlobeNewswire

Jun. 2, 2026

Crescent Biopharma to Present at June Investor Conferences

Indeterminate GlobeNewswire

Jun. 2, 2026

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Indeterminate GlobeNewswire

Jun. 2, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Verra Mobility Investors Should Contact Block & Leviton to Possibly Recover Losses; VRRM Stock Remains Down Following Avis Budget Termination

Indeterminate GlobeNewswire

Jun. 2, 2026

Senior Cybersecurity Leaders to Convene in Boston for Northeast CISO Community Forum

Indeterminate EIN Presswire